Phuong N. Huynh

Array ( [id] => 5379386 [patent_doc_number] => 20090191225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Stably Tethered Structures of Defined Compositions with Multiple Functions or Binding Specificities' [patent_app_type] => utility [patent_app_number] => 12/396965 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 45895 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191225.pdf [firstpage_image] =>[orig_patent_app_number] => 12396965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057327 [patent_doc_number] => 09096672 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/396313 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 95 [patent_no_of_words] => 50003 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12396313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580541 [patent_doc_number] => 20090175887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/396286 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 49995 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175887.pdf [firstpage_image] =>[orig_patent_app_number] => 12396286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7728530 [patent_doc_number] => 08101180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/388534 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 91 [patent_no_of_words] => 50312 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 304 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101180.pdf [firstpage_image] =>[orig_patent_app_number] => 12388534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634037 [patent_doc_number] => 08012485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Drug conjugate composition' [patent_app_type] => utility [patent_app_number] => 12/366830 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11200 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012485.pdf [firstpage_image] =>[orig_patent_app_number] => 12366830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304117 [patent_doc_number] => 20090298769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'COMPOUNDS AND METHODS OF MODULATING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/357186 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 37291 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298769.pdf [firstpage_image] =>[orig_patent_app_number] => 12357186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131981 [patent_doc_number] => 07695720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'KDR peptides and vaccines comprising the same' [patent_app_type] => utility [patent_app_number] => 12/355616 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 13013 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/695/07695720.pdf [firstpage_image] =>[orig_patent_app_number] => 12355616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564931 [patent_doc_number] => 20090137784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Epidermal Growth Factor Receptor Polypeptides and Antibodies' [patent_app_type] => utility [patent_app_number] => 12/353225 [patent_app_country] => US [patent_app_date] => 2009-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14196 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137784.pdf [firstpage_image] =>[orig_patent_app_number] => 12353225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110345 [patent_doc_number] => 20110189206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Antibody Targeting Through a Modular Recognition Domain' [patent_app_type] => utility [patent_app_number] => 12/747883 [patent_app_country] => US [patent_app_date] => 2008-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12856 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189206.pdf [firstpage_image] =>[orig_patent_app_number] => 12747883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545368 [patent_doc_number] => 20090155245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Treatment for Organ Regeneration with Combination of Drug and Biologics' [patent_app_type] => utility [patent_app_number] => 12/330704 [patent_app_country] => US [patent_app_date] => 2008-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4977 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155245.pdf [firstpage_image] =>[orig_patent_app_number] => 12330704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4511726 [patent_doc_number] => 07910098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => 'Anti-VEGF antibodies' [patent_app_type] => utility [patent_app_number] => 12/315220 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 45733 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910098.pdf [firstpage_image] =>[orig_patent_app_number] => 12315220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055931 [patent_doc_number] => 20110112291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'STABILIZATION OF CONJUGATES COMPRISING A THIOUREA LINKER' [patent_app_type] => utility [patent_app_number] => 12/323942 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4739 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112291.pdf [firstpage_image] =>[orig_patent_app_number] => 12323942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5472962 [patent_doc_number] => 20090246128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'COMPOSITION AND METHOD FOR DETECTION OF PRE-METASTATIC SITES' [patent_app_type] => utility [patent_app_number] => 12/270932 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4730 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246128.pdf [firstpage_image] =>[orig_patent_app_number] => 12270932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545405 [patent_doc_number] => 20090155282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/268352 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 46933 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155282.pdf [firstpage_image] =>[orig_patent_app_number] => 12268352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546913 [patent_doc_number] => 20090156790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/268363 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 46945 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156790.pdf [firstpage_image] =>[orig_patent_app_number] => 12268363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166885 [patent_doc_number] => 08592563 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (VEGF)' [patent_app_type] => utility [patent_app_number] => 12/739619 [patent_app_country] => US [patent_app_date] => 2008-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 18213 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6602338 [patent_doc_number] => 20100098772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING NEOVASCULARIZATION' [patent_app_type] => utility [patent_app_number] => 12/255497 [patent_app_country] => US [patent_app_date] => 2008-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14138 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098772.pdf [firstpage_image] =>[orig_patent_app_number] => 12255497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282471 [patent_doc_number] => 08216571 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Fully human anti-VEGF antibodies and methods of using' [patent_app_type] => utility [patent_app_number] => 12/739383 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 30622 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 22780 [patent_doc_number] => 07794718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Immunosuppressive polypeptides and nucleic acids' [patent_app_type] => utility [patent_app_number] => 12/251960 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 132053 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794718.pdf [firstpage_image] =>[orig_patent_app_number] => 12251960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473024 [patent_doc_number] => 20090246190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'ANTI-VEGF ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/247933 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9327 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246190.pdf [firstpage_image] =>[orig_patent_app_number] => 12247933 [rel_patent_id] =>[rel_patent_doc_number] =>)